Korro Bio, Inc. Common Stock KRRO
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T02:53:16.971Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:00.488619796Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:48:00.449791+00:00
Korro Bio, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 10.11 | 588.8% | 46.8% | |||
| 25Δ | 11.39 | 492.0% | 38.0% | |||
| 30Δ | 12.59 | 401.3% | 29.6% | |||
| 35Δ | 13.30 | 352.9% | 24.7% | |||
| 40Δ | 14.02 | 304.6% | 19.7% | |||
| 45Δ | 20.09 | 452.4% | 56.0% | 14.73 | 256.3% | 14.8% |
| 50Δ | 17.27 | 383.7% | 36.9% | |||
| 55Δ | 15.39 | 316.8% | 23.8% | |||
| 60Δ | 14.33 | 293.6% | 18.1% | |||
| 65Δ | 13.49 | 281.7% | 14.3% | |||
| 70Δ | 12.65 | 269.7% | 10.5% | |||
| 75Δ | 11.77 | 274.5% | 8.3% | |||
| 80Δ | 10.89 | 283.1% | 6.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.11
- IV
- 588.8%
- B/E move
- 46.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 11.39
- IV
- 492.0%
- B/E move
- 38.0%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 12.59
- IV
- 401.3%
- B/E move
- 29.6%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.30
- IV
- 352.9%
- B/E move
- 24.7%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 14.02
- IV
- 304.6%
- B/E move
- 19.7%
45Δ
- Pseudo strike
- 20.09
- IV
- 452.4%
- B/E move
- 56.0%
- Pseudo strike
- 14.73
- IV
- 256.3%
- B/E move
- 14.8%
50Δ
- Pseudo strike
- 17.27
- IV
- 383.7%
- B/E move
- 36.9%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 15.39
- IV
- 316.8%
- B/E move
- 23.8%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 14.33
- IV
- 293.6%
- B/E move
- 18.1%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 13.49
- IV
- 281.7%
- B/E move
- 14.3%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 12.65
- IV
- 269.7%
- B/E move
- 10.5%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 11.77
- IV
- 274.5%
- B/E move
- 8.3%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 10.89
- IV
- 283.1%
- B/E move
- 6.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 205.30% | |
| 202.71% | |
| 201.13% | |
| 153.14% | |
| 156.12% | |
| 156.26% | |
| 143.64% | |
| 130.41% | |
| 138.64% | |
| 136.04% |
Biotechnology
KRYS
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company…
More →KURA
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego,…
More →KYMR
Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins…
More →KYTX
Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health challenges. Employing…
More →KZIA
Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.
More →LBRX
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.…
More →